Ticker Details
BeiGene, Ltd. American Depositary Shares
IPO Date:	July 25, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$34.79B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$3.98 | 1.40%
Avg Daily Range (30 D):	$4.12 | 1.39%
Avg Daily Range (90 D):	$4.16 | 1.30%

Institutional Daily Volume
Avg Daily Volume:	.03M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	33
Avg Trade Size (Sh.) (30 D):	26
Avg Trade Size (Sh.) (90 D):	24

Institutional Trades
Total Institutional Trades:	481
Avg Institutional Trade:	$6.59M
Avg Institutional Trade (30 D):	$4.96M
Avg Institutional Trade (90 D):	$6.36M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.68M
Avg Closing Trade (30 D):	$5.1M
Avg Closing Trade (90 D):	$6.5M
Avg Closing Volume:	23.83K

News

Mar 23, 2026 @ 1:00 PM Molecular Partners Publishes Invitation to Annual ... Source: Na

Feb 12, 2026 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: Na

Jan 29, 2026 @ 5:28 PM FDA Accepts Summit's Lung Cancer Drug Application,... Source: Vandana Singh

Jan 27, 2026 @ 11:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Jan 6, 2026 @ 6:34 PM Ziihera® (zanidatamab-hrii) Combinations Achiev... Source: Zymeworks Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.2	$.04	$.2
Diluted EPS	$.19	$.04	$.19
Revenue	$5.34B	$1.5B	$5.34B
Gross Profit	$4.67B	$1.36B	$4.67B
Net Income / Loss	$286.93M	$66.5M	$286.93M
Operating Income / Loss	$447.14M	$185.04M	$447.14M
Cost of Revenue	$668.54M	$142.42M	$668.54M
Net Cash Flow	$1.97B	$499.11M	$1.97B
PE Ratio	1,628.21